Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Researchers find cognitive function could be improved with hormone therapy

Staff Writer
Staff Writer 3 years ago
Updated 2019/11/08 at 6:55 PM
Share
SHARE

New research is strengthening past considerations on the effectiveness of estrogen in improving cognitive function.

In the study, published in Menopause, researchers turned to over 2,000 postmenopausal women to better comprehend the correlation between estrogen and cognitive decline, as highlighted in previous findings.

The study lasted for a period of 12 years, according to researchers.

Researchers considered the use of hormone therapy, number of pregnancies, and duration of breastfeeding, among other factors, during their assessment of the participant’s duration of exposure to estrogen.

Among the participants, the findings demonstrated improved cognitive function during a longer duration of estrogen exposure. Additionally, with hormone therapy, the beneficiary effects improved cognitive health even further, the findings indicated.

“Although the assessment of the risk-to-benefit balance of hormone therapy use is complicated and must be individualized, this study provides additional evidence for beneficial cognitive effects of hormone therapy, particularly when initiated early after menopause,” said Stephanie Faubion, Director of The North American Menopause Society.

“This study also underscores the potential adverse effects of early estrogen deprivation on cognitive health in the setting of premature or early menopause without adequate estrogen replacement.”

You Might Also Like

Type 2 diabetes may lead to a significant increase in brain aging and cognitive decline

Study finds no structural brain change during mindfulness-based stress training

Study finds diet may be a contributing factor in ADHD symptoms associated in children

New research claims COVID-19 contagion may raise the risk of neurodegenerative disorder

ALS experimental drug NU-9 more efficacious than existing FDA-approved drugs

TAGGED: estrogen, hormone therapy, cognition
Staff Writer November 8, 2019
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Avocado consumption linked to a lower risk of obesity and diabetes
Next Article Post-traumatic stress disorder may increase the risk of infections

Recommended

Clinical

Type 2 diabetes may lead to a significant increase in brain aging and cognitive decline

1 Min Read
Clinical

Study finds no structural brain change during mindfulness-based stress training

1 Min Read
Clinical

Study finds diet may be a contributing factor in ADHD symptoms associated in children

1 Min Read
Clinical

New research claims COVID-19 contagion may raise the risk of neurodegenerative disorder

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?